170 related articles for article (PubMed ID: 10514288)
21. Agonist activity at the kinin B1 receptor: structural requirements of the central tetrapeptide.
Rovero P; Pellegrini M; Di Fenza A; Meini S; Quartara L; Maggi CA; Formaggio F; Toniolo C; Mierke DF
J Med Chem; 2001 Jan; 44(2):274-8. PubMed ID: 11170638
[TBL] [Abstract][Full Text] [Related]
22. Characterization of bradykinin B(2) receptor antagonists in human and rat urinary bladder.
Meini S; Patacchini R; Giuliani S; Lazzeri M; Turini D; Maggi CA; Lecci A
Eur J Pharmacol; 2000 Jan; 388(2):177-82. PubMed ID: 10666510
[TBL] [Abstract][Full Text] [Related]
23. Functional characterization of bradykinin analogues on recombinant human bradykinin B(1) and B(2) receptors.
Simpson PB; Woollacott AJ; Hill RG; Seabrook GR
Eur J Pharmacol; 2000 Mar; 392(1-2):1-9. PubMed ID: 10748265
[TBL] [Abstract][Full Text] [Related]
24. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
[TBL] [Abstract][Full Text] [Related]
25. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.
Cloutier F; Ongali B; Campos MM; Thibault G; Neugebauer W; Couture R
Br J Pharmacol; 2004 May; 142(2):285-96. PubMed ID: 15066903
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate.
Srinivasan D; Burbach LR; Daniels DV; Ford AP; Bhattacharya A
Br J Pharmacol; 2004 May; 142(2):297-304. PubMed ID: 15155537
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and pharmacological evaluation of dimer derivatives of the bradykinin receptor antagonist HOE-140.
Daffix I; Amblard M; Bergé G; Dodey P; Pruneau D; Paquet JL; Fouchet C; Franck RM; Defrêne E; Luccarini JM; Bélichard P; Martinez J
J Pept Res; 1998 Jul; 52(1):1-14. PubMed ID: 9716245
[TBL] [Abstract][Full Text] [Related]
28. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation.
Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F
J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors.
Deekonda S; Rankin D; Davis P; Lai J; Porreca F; Hruby VJ
Bioorg Med Chem Lett; 2015 Oct; 25(19):4148-52. PubMed ID: 26316468
[TBL] [Abstract][Full Text] [Related]
30. Characterization of bradykinin receptors in canine cultured corneal epithelial cells: pharmacological and functional studies.
Huang SC; Hsiao LD; Chien CS; Wang CC; Chiu CT; Tsai RJ; Yang CM
J Biomed Sci; 2002; 9(3):213-22. PubMed ID: 12065896
[TBL] [Abstract][Full Text] [Related]
31. HOE 140, a new highly potent and long-acting bradykinin antagonist in conscious rats.
Bao G; Qadri F; Stauss B; Stauss H; Gohlke P; Unger T
Eur J Pharmacol; 1991 Jul; 200(1):179-82. PubMed ID: 1769370
[TBL] [Abstract][Full Text] [Related]
32. Regulation of mitogenesis by kinins in arterial smooth muscle cells.
Dixon BS; Dennis MJ
Am J Physiol; 1997 Jul; 273(1 Pt 1):C7-20. PubMed ID: 9252437
[TBL] [Abstract][Full Text] [Related]
33. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
Butt SK; Dawson LG; Hall JM
Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
[TBL] [Abstract][Full Text] [Related]
34. Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue.
Gera L; Roy C; Bawolak MT; Bouthillier J; Adam A; Marceau F
Pharmacol Res; 2011 Nov; 64(5):528-34. PubMed ID: 21864683
[TBL] [Abstract][Full Text] [Related]
35. The longitudinal muscle of rat ileum as a sensitive monoreceptor assay for bradykinin B1 receptors.
Meini S; Lecci A; Maggi CA
Br J Pharmacol; 1996 Apr; 117(8):1619-24. PubMed ID: 8732268
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of new linear and cyclic bradykinin antagonists.
Thurieau C; Félétou M; Hennig P; Raimbaud E; Canet E; Fauchère JL
J Med Chem; 1996 May; 39(10):2095-101. PubMed ID: 8642569
[TBL] [Abstract][Full Text] [Related]
37. The pharmacology of T-kinin and des-Arg(11)-T-kinin in primary cultures of rat bladder smooth muscle cells.
Davis C; Burgess G
Eur J Pharmacol; 2002 Aug; 450(2):123-30. PubMed ID: 12206850
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological and functional characterization of the guinea-pig B2 bradykinin receptor stably expressed in CHO-K1 cell line.
Robert C; Pruneau D; Paquet JL
Br J Pharmacol; 2002 Jan; 135(2):462-8. PubMed ID: 11815382
[TBL] [Abstract][Full Text] [Related]
39. Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.
Santos EL; de Picoli Souza K; Cibrián-Uhalte E; Oliveira SM; Bader M; Costa-Neto CM; Oliveira L; Pesquero JB
Int Immunopharmacol; 2008 Feb; 8(2):282-8. PubMed ID: 18182241
[TBL] [Abstract][Full Text] [Related]
40. Cyclic and linear bradykinin analogues: implications for B2 antagonist design.
Hsieh KH; Stewart JM
J Pept Res; 1999 Jul; 54(1):23-31. PubMed ID: 10448967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
